Fenofibrate abrogates postprandial blood viscosity among hypertriglyceridemia subjects with the metabolic syndrome

Fenofibrate lowers postprandial blood viscosity at low and high shear rates, and this hemorheological effect may contribute to the observed improvement in microvascular disease in patients treated with fenofibrate.